Fibrosing colonopathy
Background
- Disease that occurs in patients with cystic fibrosis treated with enteric coated pancreatic enzymes, particularly with high doses[1]
- More common in children, but reported in adults
- Characterized by progressive submucosal fibrosis, particularly of the proximal colon
Clinical Features
- Abdominal pain/distension, vomiting, constipation, failure to thrive
- +/- bloody diarrhea
- May present similarly to distal bowel obstruction[2]
Differential Diagnosis
0–3 Months Old
- Emergent
- Nonemergent
3 mo–3 y old
- Emergent
- Intussusception
- Testicular Torsion
- Trauma
- Volvulus
- Appendicitis
- Toxic megacolon
- Vaso-occlusive crisis
- Nonemergent
3 y old–adolescence
- Emergent
- Appendicitis
- DKA
- Vaso-occlusive crisis
- Toxic ingestion
- Testicular Torsion
- Ovarian Torsion
- Ectopic Pregnancy
- Trauma
- Toxic megacolon
- Inflammatory bowel disease
- Gastric ulcer disease
- Ovarian cyst
- Pregnancy
- Pancreatitis
- Cholecystitis
- Intussusception (to age 6)
- Nonemergent
Evaluation
Management[5]
- Anti-inflammatory therapy (e.g. prednisone pulses)
- Definitive treatment is balloon dilation or surgical resection of structured portion of colon
Disposition
See Also
External Links
References
- Fitzsimmons SC, Burkhart GA, Borowitz D, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med. 1997;336(18):1283-9.
- Rosenstein BJ, Langbaum TS (May 1983). "Incidence of distal intestinal obstruction syndrome in cystic fibrosis". Journal of Pediatric Gastroenterology and Nutrition. 2 (2): 299–301
- https://radiopaedia.org/articles/fibrosing-colonopathy-1?lang=us
- https://www.sciencedirect.com/topics/neuroscience/fibrosing-colonopathy
- https://www.sciencedirect.com/topics/neuroscience/fibrosing-colonopathy
This article is issued from
Wikem.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.